Sector Chart Kintara Therapeutics, Inc.

Equities

KTRA

US49720K2006

Delayed Nasdaq 15:59:11 2024-05-21 EDT 5-day change 1st Jan Change
0.1798 USD +2.74% Intraday chart for Kintara Therapeutics, Inc. +40.16% +5.78%
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
9.68M - - - - -
115B
107B
22.31B -
21.6B -
18.23B -
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW